Literature DB >> 22091235

A pulmonary aspergillosis case with fatal course in a patient with SIRS clinic.

Nedim Cekmen1, Sonay Açiksöz, Hacer Serdaroğlu, Ozcan Erdemli.   

Abstract

A 77-year-old male patient with a history of tuberculosis applied to emergency service with complaints of confusion, shortness of breath, tachycardia, hypothermia and hypotension. A bronchoalveolar lavage culture was collected because a fungus ball was seen on repeat chest X-ray and thoracic CT of the patient. Aspergillus fumigatus grew and voricona-zole treatment was started, but the patient was lost from multiple organ failure (MOF). In diagnosis of patients with SIRS clinic, causative factor may be aspergillus located in an old tuberculosis cavity, and this may have a fatal course in an old patient having previous pulmonary and systemic diseases.

Entities:  

Keywords:  Morbidity; Mortality; Multiple Organ Failure; Pulmonary Aspergillosis; Systemic Inflammatory Response Syndrome

Year:  2011        PMID: 22091235      PMCID: PMC3214307     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


  12 in total

Review 1.  The radiological spectrum of pulmonary aspergillosis.

Authors:  R Greene
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

2.  Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.

Authors:  Helen Sambatakou; Bertrand Dupont; Hartmut Lode; David W Denning
Journal:  Am J Med       Date:  2006-06       Impact factor: 4.965

Review 3.  Management of sepsis in the ICU.

Authors:  Ewa Trejnowska; Marc J Popovich
Journal:  Int Anesthesiol Clin       Date:  2009

4.  Pulmonary aspergilloma: analysis of prognosis in relation to symptoms and treatment.

Authors:  Jin Gu Lee; Chang Young Lee; In Kyu Park; Dae Joon Kim; Joon Chang; Se Kyu Kim; Kyung Young Chung
Journal:  J Thorac Cardiovasc Surg       Date:  2009-04-11       Impact factor: 5.209

5.  Hospital survival rates of patients with acute respiratory failure in modern respiratory intensive care units. An international, multicenter, prospective survey.

Authors:  S Vasilyev; R N Schaap; J D Mortensen
Journal:  Chest       Date:  1995-04       Impact factor: 9.410

Review 6.  Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis.

Authors:  Yasumasa Okazaki; Akihiro Matsukawa
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2009-01

Review 7.  Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-01-08       Impact factor: 17.440

8.  Pathology of pulmonary aspergillomas.

Authors:  Rajeev Shah; Pradeep Vaideeswar; Shobhana P Pandit
Journal:  Indian J Pathol Microbiol       Date:  2008 Jul-Sep       Impact factor: 0.740

Review 9.  Pulmonary aspergillosis: a clinical update.

Authors:  O S Zmeili; A O Soubani
Journal:  QJM       Date:  2007-06

10.  Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome.

Authors:  José Garnacho-Montero; Rosario Amaya-Villar; Carlos Ortiz-Leyba; Cristóbal León; Francisco Alvarez-Lerma; Juan Nolla-Salas; José R Iruretagoyena; Fernando Barcenilla
Journal:  Crit Care       Date:  2005-03-11       Impact factor: 9.097

View more
  1 in total

1.  In vivo efficacy of a synthetic coumarin derivative in a murine model of aspergillosis.

Authors:  Seema Singh; Rajesh Dabur; Madhumanjiri M Gatne; Bharat Singh; Shilpi Gupta; Sharad Pawar; Sunil K Sharma; Gainda L Sharma
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.